Researchers evaluated patient perceptions of the ketogenic diet. The analysis included 3-month follow-up from 52 participants with relapsing multiple sclerosis previously enrolled in a prospective 6-month ketogenic diet trial.

Researchers sought to determine if and when disease-modifying therapies should be discontinued in older adults with multiple sclerosis.

Amino acid metabolism is altered in people with multiple sclerosis and influenced by the clinical type of disease.

Researchers sought to examine the association between patients’ disability, fatigue, and accelerometer-measured physical activity.

The FDA has accepted for review the NDA for glatiramer acetate depot 40 mg for the treatment of relapsing forms of multiple sclerosis.

There is not enough evidence to support the use of spinal cord stimulation over the current medical standard of care to reduce spasticity linked to MS.

Oral disease-modifying therapies (DMTs) predominated new initiations for treatment of multiple sclerosis (MS) in 2020.

In a meta-analysis, researchers evaluated the relationship between Chlamydia pneumoniae infection and the development of multiple sclerosis.

For patients with MS with a first demyelinating event, earlier treatment initiation is associated with a reduction in the risk for long-term disability.

Positive data were announced from a phase 3 trial evaluating an investigational SC formulation of ocrelizumab in patients with MS.

In a cross-sectional study, researchers assessed global data surrounding MS diagnosis from the Multiple Sclerosis International Federation (MSIF) third edition of the Atlas of MS survey.

In a retrospective data analysis, researchers examined the extent to which a twice-daily alertness test is associated with fatigue related to multiple sclerosis.

Researchers assessed the relapse rates among patients with highly active relapsing multiple sclerosis who received treatment with either cladribine or fingolimod.

For people with MS, a pro-inflammatory diet is linked to worsening relapse rate and greater periventricular fluid-attenuated inversion recovery lesion volume.

An evaluation reviewed the connection between OCT findings and the course of multiple sclerosis.

Researchers described the prevalence of cannabis use in adults with chronic pain condition and multiple sclerosis.

For patients with relapsing-remitting multiple sclerosis (MS), rituximab is not noninferior to ocrelizumab.

White individuals have the highest prevalence of multiple sclerosis (MS), according to a study published online.

Researchers sought to assess the overall impact of exercise interventions on HRQOL in patients with MS, the overall strength of evidence of exercise interventions on the physical and mental domains of HRQOL, and establish moderators of exercise intervention effects on HRQOL.

In a large population-based study, researchers determined the associations between MS during pregnancy and the risk for perinatal adverse outcomes.

Researchers sought to evaluate whether fertility, pregnancy, delivery, and breastfeeding have been improving among women with MS, compared with the general population, and in relation to treatment features.

Researchers sought to characterize immune responses to SARS-CoV-2 vaccinations among patients with MS who received anti-CD20 therapy and who were vaccinated 2 to 4 times.

Researchers sought to assess the characteristics of patients who discontinued first-line DMT, and the occurrence of clinical and radiologic inflammatory disease activity following DMT discontinuation.

Researchers sought to assess the impact of smoking habits, exposure to passive smoking, and snuff use on disease progression, cognitive performance, and quality of life in patients with MS.

In a systematic review, researchers examined the effects of music therapy intervention on patients with multiple sclerosis with gait disorders.

In an observational retrospective study, researchers evaluated annualized relapse rate 12 months pre-fertility treatment and 3 months post-fertility treatment and identified factors related with increased relapse risk.

In a retrospective cohort study, researchers evaluated the differences in fracture risk between patients with NMOSD and MS compared to that of healthy individuals.

For women with multiple sclerosis (MS), there is no increased relapse rate after fertility treatment (FT).

Researchers assessed the relationship between higher ocrelizumab exposure and confirmed disability progression.

In a randomized controlled trial, researchers assessed the effects of TR and V-TOXT on upper limb, trunk function, and functional activity kinematics in patients with MS.